Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Bujanda

Showing results (371-380 of 423) with videos related to

Pageof 43
Sort By:
Alimentary Pharmacology & Therapeutics|April 24, 2023
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH studyMaría José Casanova, Óscar Nantes, Pilar Varela, et al.
Helicobacter|July 13, 2024
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg)Samuel J Martínez-Domínguez, Olga P Nyssen, Ángel Lanas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2021
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Ángeles Pérez Aísa, et al.
Therapeutic Advances in Gastroenterology|February 24, 2026
Hidradenitis suppurativa in patients with inflammatory bowel disease: a national multicenter study from the GETECCU-ENEIDA RegistryLucía Madero-Velázquez, Ruth de Francisco, Belen Herreros, et al.
Helicobacter|March 17, 2020
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)Olga P Nyssen, Ángeles Pérez-Aisa, Bojan Tepes, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortalityTomoko Nakanishi, Sara Pigazzini, Frauke Degenhardt, et al.
The American Journal of Gastroenterology|February 4, 2025
Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg)Diego Casas Deza, Javier Alcedo, Miguel Lafuente, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 5, 2026
Higher doses of Bismuth and antibiotics do not improve H. pylori treatment effectiveness: results from the Hp-EuRegSamuel J Martínez-Domínguez, Ángel Lanas, Enrique Ceamanos, et al.
Gastroenterology|May 2, 2025
Gene-specific Detection Rate of Adenomas and Advanced Adenomas in Lynch SyndromeAriadna Sánchez, Joaquin Castillo-Iturra, Victorine H Roos, et al.
Antibiotics (Basel, Switzerland)|September 28, 2023
Analysis of Clinical Phenotypes through Machine Learning of First-Line <i>H. pylori</i> Treatment in Europe during the Period 2013-2022: Data from the European Registry on <i>H. pylori</i> Management (Hp-EuReg)Olga P Nyssen, Pietro Pratesi, Miguel A Spínola, et al.
Pageof 43

Showing results (371-380 of 423) with videos related to

Sort By:
Pageof 43
Alimentary Pharmacology & Therapeutics|April 24, 2023
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH studyMaría José Casanova, Óscar Nantes, Pilar Varela, et al.
Helicobacter|July 13, 2024
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg)Samuel J Martínez-Domínguez, Olga P Nyssen, Ángel Lanas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2021
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Ángeles Pérez Aísa, et al.
Therapeutic Advances in Gastroenterology|February 24, 2026
Hidradenitis suppurativa in patients with inflammatory bowel disease: a national multicenter study from the GETECCU-ENEIDA RegistryLucía Madero-Velázquez, Ruth de Francisco, Belen Herreros, et al.
Helicobacter|March 17, 2020
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)Olga P Nyssen, Ángeles Pérez-Aisa, Bojan Tepes, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortalityTomoko Nakanishi, Sara Pigazzini, Frauke Degenhardt, et al.
The American Journal of Gastroenterology|February 4, 2025
Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg)Diego Casas Deza, Javier Alcedo, Miguel Lafuente, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 5, 2026
Higher doses of Bismuth and antibiotics do not improve H. pylori treatment effectiveness: results from the Hp-EuRegSamuel J Martínez-Domínguez, Ángel Lanas, Enrique Ceamanos, et al.
Gastroenterology|May 2, 2025
Gene-specific Detection Rate of Adenomas and Advanced Adenomas in Lynch SyndromeAriadna Sánchez, Joaquin Castillo-Iturra, Victorine H Roos, et al.
Antibiotics (Basel, Switzerland)|September 28, 2023
Analysis of Clinical Phenotypes through Machine Learning of First-Line <i>H. pylori</i> Treatment in Europe during the Period 2013-2022: Data from the European Registry on <i>H. pylori</i> Management (Hp-EuReg)Olga P Nyssen, Pietro Pratesi, Miguel A Spínola, et al.
Pageof 43